Clinical Study
Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis
Table 2
In vitro susceptibility of Fusarium, Aspergillus, and Dematiaceous isolates to antifungal agents.
| Isolate (number) | Agent, G-MIC (range) | Natamycin | Amphotericin B | Fluconazole | Itraconazole |
| Fusarium solani | 29.3 (8–128) | 6.3 (1–32) | 128 (≥128) | 113.7 (64–128) | Fusarium delphinoides | 12 (8–16) | 12 (8–16) | 128 (≥128) | 128 (≥128) | Aspergillus flavus | 32 (32) | 0.35 (0.2–0.5) | 128 (≥128) | 1.5 (1–2) | Aspergillus terreus | 13.3 (8–16) | 2.5 (1–3) | 26.6 (16–32) | 0.25 (0.25) | Aspergillus niger | 8 | 0.06 | 128 | 64 | Aspergillus tamarii | 64 | 0.25 | ≥128 | 0.25 | Aspergillus tubingensis | 8 | 2 | 32 | 0.25 | Aspergillus sydowii | 4 | 4 | ≥128 | ≥128 | Aspergillus versicolor | 4 | 2 | 32 | 0.25 | Curvularia lunata | 12.5 (2–32) | 16 (0.25–32) | 128 (≥128) | 128 (≥128) | Exherohelum rostratum | 2 (2–4) | 1 (0.5–2) | 32 (32) | 0.25 (0.25–0.5) | Cladorrhinum bulbilossum | 0.064 | 0.064 | 0.32 | 0.016 | Lasiodiplodia theobromae | 0.064 | 0.064 | 0.32 | 0.016 | Papulaspora spp. | 0.064 | 0.064 | 0.32 | 0.016 |
|
|
Geometric mean of MIC.
|